Security key
68622P109
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)
CUSIP: 68622P109
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 79,209,337
- Total 13F value
- $442,004,992
- Share change
- +3,416,738
- Put/Call ratio
- 24%
- SEC-reported price per share
- $5.58
- Number of holders
- 142
- Value change
- +$11,923,513
- Number of buys
- 79
- Number of sells
- 55
- Shares outstanding
- 105,956,500
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
142
Top holders
10
ORIC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Oric Pharmaceuticals, Inc. SEC filings
Oric Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68622P109
Recent filing periods:
Ownership snapshot
Top reported holders of ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
PFIZER INC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
13D/G
3/4/5
Lead comparable stake: 3.5%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 3.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
3.5%
Frazier Life Sciences Public Fund...
2%
PFIZER INC
5.1%
Nextech Invest Ltd.
5%
BlackRock, Inc.
4.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
Company
|
3.5%
from 13D/G
|
$19,915,216
2,467,809 shares
|
— | 31 Dec 2024 |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
James N. Topper
|
2%
|
$7,981,692
1,410,193 shares
|
$0 | 31 Mar 2025 |
| PFIZER INC |
3/4/5
13F
10%+ Owner · Company
|
5.1%
from 13F
|
$46,160,752
5,376,344 shares
|
— | 23 Dec 2022 |
| Nextech Invest Ltd. |
13F
Company
|
5%
|
$42,655,712
5,285,714 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
4.8%
|
$41,262,183
5,113,034 shares
|
— | 31 Dec 2024 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
4.2%
|
$35,758,235
4,431,008 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
142
Shares
79,209,337
Rows available
142
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
142
Q1 2025 holders
142
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend